Efficacy and safety of hepatitis B vaccine: an umbrella review of meta-analyses

References

• Pattyn J, Hendrickx G, Vorsters A, Van DP. Hepatitis B Vaccines. J Infect Dis. 2021;2241:S343–S351. doi: 10.1093/infdis/jiaa668. PubMed PMID: 34590138.
   PubMedGoogle Scholar
• Cooke GS, Andrieux-Meyer I, Applegate TL, et al. Accelerating the elimination of viral hepatitis: a lancet gastroenterology & hepatology commission. Lancet Gastroenterol Hepatol. 2019 Feb;4(2):135–184. PubMed PMID: 30647010. doi: 10.1016/S2468-1253(18)30270-X
   PubMed Web of Science ®Google Scholar
• Guidotti LG, Chisari FV. Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol. 2006;1:23–61. PubMed PMID: 18039107. doi: 10.1146/annurev.pathol.1.110304.100230
   PubMed Web of Science ®Google Scholar
• Health Organization W, World Health O. Hepatitis B vaccines: WHO position paper, July 2017 – recommendations. Vaccine. 2019 Jan 7;37(2):223–225. PubMed PMID: 28743487. 10.1016/j.vaccine.2017.07.046
   PubMed Web of Science ®Google Scholar
• de Villiers MJ, Nayagam S, Hallett TB. The impact of the timely birth dose vaccine on the global elimination of hepatitis B. Nat Commun. 2021 Oct 28;12(1):6223. doi: 10.1038/s41467-021-26475-6. PubMed PMID: 34711822; PMCID: PMCPMC8553835.
   PubMed Web of Science ®Google Scholar
• Zhang LL, Guo J, Duan K. Comparative analysis of the safety and efficacy of HBsAg-1018 versus HBsAg-eng: a meta-analysis. Cent Eur J Immunol. 2019;44(4):455–462. PubMed PMID: 32140059; PubMed Central PMCID: PMCPMC7050062. doi: 10.5114/ceji.2019.92808
   PubMed Web of Science ®Google Scholar
• Leuridan E, Van Damme P. Hepatitis B and the need for a booster dose. Clin Infect Dis. 2011 Jul 1;53(1):68–75. PubMed PMID: 21653306. 10.1093/cid/cir270
   PubMed Web of Science ®Google Scholar
• Di Lello FA, Martinez AP, Flichman DM. Insights into induction of the immune response by the hepatitis B vaccine. World J Gastroenterol. 2022 Aug 21;28(31):4249–4262. PubMed PMID: 36159002; PubMed Central PMCID: PMCPMC9453777. 10.3748/wjg.v28.i31.4249
   PubMed Web of Science ®Google Scholar
• Poorolajal J, Mahmoodi M, Majdzadeh R, et al. Long-term protection provided by hepatitis B vaccine and need for booster dose: a meta-analysis. Vaccine. 2010 Jan 8;28(3):623–631. PubMed PMID: 19887132. doi: 10.1016/j.vaccine.2009.10.068
   PubMed Web of Science ®Google Scholar
• Chen W, Gluud C. Vaccines for preventing hepatitis B in health-care workers. Cochrane Database Syst Rev. 2005 Oct;19(4):Cd000100. doi: 10.1002/14651858.CD000100.pub3. PubMed PMID: 16235273; eng.
   Google Scholar
• Hess G, Hingst V, Cseke J, et al. Influence of vaccination schedules and host factors on antibody response following hepatitis B vaccination. Eur J Clin Microbiol Infect Dis. 1992 Apr;11(4):334–340. PubMed PMID: 1396753. doi: 10.1007/BF01962073
   PubMed Web of Science ®Google Scholar
• Ricciardi G, Graziano G. [Safety and immunogenicity of an anti-hepatitis-B vaccine obtained using the recombinant DNA technique: results of a longitudinal study in hospital personnel]. Boll Ist Sieroter Milan. 1990 Jun;69(2):385–90. PubMed PMID: 2152297.
   PubMedGoogle Scholar
• Chung S, Roh EY, Park B, et al. GWAS identifying HLA-DPB1 gene variants associated with responsiveness to hepatitis B virus vaccination in Koreans: Independent association of HLA-DPB1*04: 02 possessing rs1042169 G - rs9277355 C - rs9277356 a. J Viral Hepat. 2019 Nov;26(11):1318–1329. PubMed PMID: 31243853. doi: 10.1111/jvh.13168
   PubMed Web of Science ®Google Scholar
• Akcay IM, Katrinli S, Ozdil K, et al. Host genetic factors affecting hepatitis B infection outcomes: insights from genome-wide association studies. World J Gastroenterol. 2018 Aug 14;24(30): 3347–3360. PubMed PMID: 30122875; PubMed Central PMCID: PMCPMC6092584. 10.3748/wjg.v24.i30.3347
   PubMed Web of Science ®Google Scholar
• Shlomai A, Shaul Y. The “metabolovirus” model of hepatitis B virus suggests nutritional therapy as an effective anti-viral weapon. Med Hypotheses. 2008;71(1):53–57. PubMed PMID: 18334285 doi: 10.1016/j.mehy.2007.08.032
   PubMed Web of Science ®Google Scholar
• Hyer RN, Janssen RS. Immunogenicity and safety of a 2-dose hepatitis B vaccine, HBsAg/CpG 1018, in persons with diabetes mellitus aged 60–70 years. Vaccine. 2019 Sep 16;37(39):5854–5861. PubMed PMID: 31431412. 10.1016/j.vaccine.2019.08.005
   PubMed Web of Science ®Google Scholar
• Liu F, Guo Z, Dong C. Influences of obesity on the immunogenicity of hepatitis B vaccine. Hum Vaccin Immunother. 2017 May 4;13(5):1014–1017. PubMed PMID: 28059607; PubMed Central PMCID: PMCPMC5443393. 10.1080/21645515.2016.1274475
   PubMed Web of Science ®Google Scholar
• Verstraeten T, Fletcher MA, Suaya JA, et al. Diabetes mellitus as a vaccine-effect modifier: a review. Expert Rev Vaccines. 2020 May;19(5):445–453. PubMed PMID: 32516066. doi: 10.1080/14760584.2020.1760098
   PubMed Web of Science ®Google Scholar
• Zhang L, Xu A, Yan B, et al. A significant reduction in hepatitis B virus infection among the children of Shandong Province, China: the effect of 15 years of universal infant hepatitis B vaccination. Int J Infect Dis. 2010 Jun;14(6):e483–8. PubMed PMID: 19939719. doi: 10.1016/j.ijid.2009.08.005
   PubMed Web of Science ®Google Scholar
• Siddaway AP, Wood AM, Hedges LV. How to do a systematic review: a best practice guide for conducting and reporting narrative reviews, meta-analyses, and meta-syntheses. Annu Rev Psychol. 2019 Jan 4;70(1):747–770. PubMed PMID: 30089228. 10.1146/annurev-psych-010418-102803
   PubMedGoogle Scholar
• Aromataris E, Fernandez R, Godfrey CM, et al. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc. 2015 Sep;13(3):132–40. PubMed PMID: 26360830. doi: 10.1097/XEB.0000000000000055
   PubMed Web of Science ®Google Scholar
• Smith V, Devane D, Begley CM, et al. Methodology in conducting a systematic review of systematic reviews of healthcare interventions. BMC Med Res Methodol. 2011 Feb 3;11(1):15. PubMed PMID: 21291558; PubMed Central PMCID: PMCPMC3039637. doi: 10.1186/1471-2288-11-15
   PubMedGoogle Scholar
• Jack AD, Hall AJ, Maine N, et al. What level of hepatitis B antibody is protective? J Infect Dis. 1999 Feb;179(2):489–492. PubMed PMID: 9878036. doi: 10.1086/314578
   PubMed Web of Science ®Google Scholar
• Mouchet J, Salvo F, Raschi E, et al. Hepatitis B vaccination and the putative risk of central demyelinating diseases - a systematic review and meta-analysis. Vaccine. 2018 Mar 14;36(12): 1548–1555. PubMed PMID: 29454521. 10.1016/j.vaccine.2018.02.036
   PubMed Web of Science ®Google Scholar
• Guyatt G, Oxman AD, Akl EA, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011 Apr;64(4):383–94. PubMed PMID: 21195583. DOI:10.1016/j.jclinepi.2010.04.026
   PubMed Web of Science ®Google Scholar
• Granholm A, Alhazzani W, Moller MH. Use of the GRADE approach in systematic reviews and guidelines. Br J Anaesth. 2019 Nov;123(5):554–559. PubMed PMID: 31558313. doi: 10.1016/j.bja.2019.08.015
   PubMed Web of Science ®Google Scholar
• Rojas-Rueda D, Morales-Zamora E, Alsufyani WA, et al. Environmental risk factors and Health: an umbrella review of meta-analyses. Int J Environ Res Public Health. 2021 Jan 15;18(2). PubMed PMID: 33467516; PubMed Central PMCID: PMCPMC7830944 10.3390/ijerph18020704
   Web of Science ®Google Scholar
• Gao X, Su X, Han X, et al. Unsaturated fatty acids in mental disorders: an umbrella review of meta-analyses. Adv Nutr. 2022 Dec 22;13(6):2217–2236. PubMed PMID: 36041185; PubMed Central PMCID: PMCPMC9776730. 10.1093/advances/nmac084
   PubMed Web of Science ®Google Scholar
• Piovani D, Danese S, Peyrin-Biroulet L, et al. Environmental risk factors for inflammatory bowel diseases: an umbrella review of meta-analyses. Gastroenterology. 2019 Sep;157(3):647–659.e4. PubMed PMID: 31014995. doi:10.1053/j.gastro.2019.04.016
   PubMed Web of Science ®Google Scholar
• Ioannidis JP, Tarone R, McLaughlin JK. The false-positive to false-negative ratio in epidemiologic studies. Epidemiology. 2011 Jul;22(4):450–6. doi: 10.1097/EDE.0b013e31821b506e. PubMed PMID: 21490505.
   PubMed Web of Science ®Google Scholar
• Sterne JA, Davey Smith G. Sifting the evidence-what’s wrong with significance tests? BMJ. 2001 Jan 27;322(7280):226–31. PubMed PMID: 11159626; PubMed Central PMCID: PMCPMC1119478. 10.1136/bmj.322.7280.226
   PubMedGoogle Scholar
• Cochran W. The combination of estimates from different experiments. Biometrics. 1954;10(1):101. doi: 10.2307/3001666
   Web of Science ®Google Scholar
• Ioannidis JP, Patsopoulos NA, Evangelou E. Uncertainty in heterogeneity estimates in meta-analyses. BMJ. 2007 Nov 3;335(7626):914–6. PubMed PMID: 17974687; PubMed Central PMCID: PMCPMC2048840. 10.1136/bmj.39343.408449.80
   PubMedGoogle Scholar
• Riley RD, Higgins JP, Deeks JJ. Interpretation of random effects meta-analyses. BMJ. 2011 Feb 10;342: d549. PubMed PMID: 21310794 10.1136/bmj.d549
   PubMedGoogle Scholar
• Higgins JP, Thompson SG, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc. 2009 Jan;172(1):137–159. doi: 10.1111/j.1467-985X.2008.00552.x. PubMed PMID: 19381330; PubMed Central PMCID: PMCPMC2667312.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997 Sep 13;315(7109):629–634. PubMed PMID: 9310563; PubMed Central PMCID: PMCPMC2127453. doi: 10.1136/bmj.315.7109.629
   PubMedGoogle Scholar
• Ioannidis JP, Trikalinos TA. An exploratory test for an excess of significant findings. Clin Trials. 2007;4(3):245–253. PubMed PMID: 17715249 doi: 10.1177/1740774507079441
   PubMed Web of Science ®Google Scholar
• Lubin JH, Gail MH. On power and sample size for studying features of the relative odds of disease. Am J Epidemiol. 1990 Mar;131(3):552–566. PubMed PMID: 2301364; eng. doi: 10.1093/oxfordjournals.aje.a115530
   PubMed Web of Science ®Google Scholar
• Kim JH, Kim JY, Lee J, et al. Environmental risk factors, protective factors, and peripheral biomarkers for ADHD: an umbrella review. Lancet Psychiatry. 2020 Nov;7(11):955–970. PubMed PMID: 33069318. doi: 10.1016/S2215-0366(20)30312-6
   PubMed Web of Science ®Google Scholar
• Alavian SM, Tabatabaei SV. The effect of diabetes mellitus on immunological response to hepatitis B virus vaccine in individuals with chronic kidney disease: a meta-analysis of current literature. Vaccine. 2010 May 14;28(22):3773–3777. PubMed PMID: 20371390. doi: 10.1016/j.vaccine.2010.03.038
   PubMed Web of Science ®Google Scholar
• Chen Z, Zeng M, Liu D, et al. Antenatal administration of hepatitis B immunoglobulin and hepatitis B vaccine to prevent mother to child transmission in hepatitis B virus surface antigen positive pregnant women: a systematic review and meta-analysis. Medicine (Baltimore). 2020 Apr;99(16):e19886. PubMed PMID: 32312015; PubMed Central PMCID: PMCPMC7220666. doi: 10.1097/MD.0000000000019886
   PubMed Web of Science ®Google Scholar
• Cruciani M, Mengoli C, Serpelloni G, et al. Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination: a meta-analysis. Vaccine. 2007 Jan 8;25(4):709–718. PubMed PMID: 16963165. doi: 10.1016/j.vaccine.2006.08.015
   PubMed Web of Science ®Google Scholar
• Cui W, Sun CM, Deng BC, et al. Association of polymorphisms in the interleukin-4 gene with response to hepatitis B vaccine and susceptibility to hepatitis B virus infection: a meta-analysis. Gene. 2013 Aug 1;525(1):35–40. PubMed PMID: 23651591. doi: 10.1016/j.gene.2013.04.065
   PubMed Web of Science ®Google Scholar
• Fabrizi F, Dixit V, Magnini M, et al. Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease. Aliment Pharmacol Ther. 2006 Aug 1;24(3):497–506. PubMed PMID: 16886915. doi: 10.1111/j.1365-2036.2006.03002.x
   PubMed Web of Science ®Google Scholar
• Fabrizi F, Dixit V, Martin P. Meta-analysis: the adjuvant role of thymopentin on immunological response to hepatitis B virus vaccine in end-stage renal disease. Aliment Pharmacol Ther. 2006 Jun 1;23(11):1559–66. PubMed PMID: 16696803. 10.1111/j.1365-2036.2006.02923.x
   PubMed Web of Science ®Google Scholar
• Fan W, Zhang M, Zhu YM, et al. Immunogenicity of hepatitis B vaccine in preterm or low birth weight infants: a meta-analysis. Am J Prev Med. 2020 Aug;59(2):278–287. PubMed PMID: 32564973. doi: 10.1016/j.amepre.2020.03.009
   PubMed Web of Science ®Google Scholar
• Fan W, Chen XF, Shen C, et al. Hepatitis B vaccine response in obesity: a meta-analysis. Vaccine. 2016 Sep 14;34(40):4835–4841. PubMed PMID: 27546877. doi: 10.1016/j.vaccine.2016.08.027
   PubMed Web of Science ®Google Scholar
• Ghozy S, Nam NH, Radwan I, et al. Therapeutic efficacy of hepatitis B virus vaccine in treatment of chronic HBV infections: a systematic review and meta-analysis. Rev Med Virol. 2020 May;30(3):e2089. PubMed PMID: 31811678. doi: 10.1002/rmv.2089
   PubMed Web of Science ®Google Scholar
• Jin H, Tan Z, Zhang X, et al. Comparison of accelerated and standard hepatitis B vaccination schedules in high-risk healthy adults: a meta-analysis of randomized controlled trials. PLoS One. 2015;10(7):e0133464. PubMed PMID: 26196903; PubMed Central PMCID: PMCPMC4510064. doi: 10.1371/journal.pone.0133464
   PubMed Web of Science ®Google Scholar
• Khedmat H, Aghaei A, Ghamar-Chehreh ME, et al. Sex bias in response to hepatitis B vaccination in end-stage renal disease patients: meta-analysis. World J Nephrol. 2016 Jan 6;5(1): 115–24. PubMed PMID: 26788471; PubMed Central PMCID: PMCPMC4707164. 10.5527/wjn.v5.i1.115
   PubMedGoogle Scholar
• Mahmood S, Shah KU, Khan TM. Immune persistence after infant hepatitis-B vaccination: a systematic review and meta-analysis. Sci Rep. 2018 Aug 22;8(1):12550. PubMed PMID: 30135554; PubMed Central PMCID: PMCPMC6105718. doi: 10.1038/s41598-018-30512-8
   PubMedGoogle Scholar
• Opri R, Veneri D, Mengoli C, et al. Immune response to hepatitis B vaccine in patients with celiac disease: a systematic review and meta-analysis. Hum Vaccin Immunother. 2015;11(12):2800–2805. PubMed PMID: 26378476; PubMed Central PMCID: PMCPMC5054794. doi: 10.1080/21645515.2015.1069448
   PubMed Web of Science ®Google Scholar
• Ou G, Liu X, Jiang Y. HLA-DPB1 alleles in hepatitis B vaccine response: a meta-analysis. Medicine (Baltimore). 2021 Apr 9;100(14):e24904. PubMed PMID: 33832070; PubMed Central PMCID: PMCPMC8036076. doi: 10.1097/MD.0000000000024904
   PubMed Web of Science ®Google Scholar
• Sangare L, Manhart L, Zehrung D, et al. Intradermal hepatitis B vaccination: a systematic review and meta-analysis. Vaccine. 2009 Mar 13;27(12):1777–1786. PubMed PMID: 19200451. doi: 10.1016/j.vaccine.2009.01.043
   PubMed Web of Science ®Google Scholar
• Singh AK, Jena A, Mahajan G, et al. Meta-analysis: hepatitis B vaccination in inflammatory bowel disease. Aliment Pharmacol Ther. 2022 Apr;55(8):908–920. PubMed PMID: 35261057. doi: 10.1111/apt.16880
   PubMed Web of Science ®Google Scholar
• Udomkarnjananun S, Takkavatakarn K, Praditpornsilpa K, et al. Hepatitis B virus vaccine immune response and mortality in dialysis patients: a meta-analysis. J Nephrol. 2020 Apr;33(2):343–354. PubMed PMID: 31701375. doi: 10.1007/s40620-019-00668-1
   PubMed Web of Science ®Google Scholar
• Whitford K, Liu B, Micallef J, et al. Long-term impact of infant immunization on hepatitis B prevalence: a systematic review and meta-analysis. Bull World Health Organ. 2018 Jul 1;96(7): 484–497. PubMed PMID: 29962551; PubMed Central PMCID: PMCPMC6022616. 10.2471/BLT.17.205153
   PubMed Web of Science ®Google Scholar
• Wu Z, Bao H, Yao J, et al. Suitable hepatitis B vaccine for adult immunization in China: a systematic review and meta-analysis. Hum Vaccin Immunother. 2019;15(1):220–227. PubMed PMID: 30089437; PubMed Central PMCID: PMCPMC6363055. doi: 10.1080/21645515.2018.1509172
   PubMed Web of Science ®Google Scholar
• Schillie S, Vellozzi C, Reingold A, et al. Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on immunization practices. MMWR Recomm Rep. 2018 Jan 12;67(1):1–31. PubMed PMID: 29939980;PMCID: PMC5837403. doi: 10.15585/mmwr.rr6701a1
   Google Scholar
• Watson B, West DJ, Chilkatowsky A, et al. Persistence of immunologic memory for 13 years in recipients of a recombinant hepatitis B vaccine. Vaccine. 2001 Apr 30;19(23–24):3164–3168. PubMed PMID: 11312012. doi: 10.1016/s0264-410x(01)00019-6
   PubMed Web of Science ®Google Scholar
• McMahon BJ, Bruden DL, Petersen KM, et al. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med. 2005 Mar 1;142(5):333–341. PubMed PMID: 15738452. doi: 10.7326/0003-4819-142-5-200503010-00008
   PubMed Web of Science ®Google Scholar
• Zanetti AR, Mariano A, Romano L, et al. Long-term immunogenicity of hepatitis B vaccination and policy for booster: an Italian multicentre study. Lancet. 2005 Oct 15-21;366(9494): 1379–1384. PubMed PMID: 16226616. 10.1016/S0140-6736(05)67568-X
   PubMed Web of Science ®Google Scholar
• De Gregorio E, Caproni E, Ulmer JB. Vaccine adjuvants: mode of action. Front Immunol. 2013;4:214. PubMed PMID: 23914187; PubMed Central PMCID: PMCPMC3728558. doi: 10.3389/fimmu.2013.00214
   PubMed Web of Science ®Google Scholar
• Halperin SA, Ward B, Cooper C, et al. Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18-55 years of age. Vaccine. 2012 Mar 28;30(15):2556–2563. PubMed PMID: 22326642. doi: 10.1016/j.vaccine.2012.01.087
   PubMed Web of Science ®Google Scholar
• Heyward WL, Kyle M, Blumenau J, et al. Immunogenicity and safety of an investigational hepatitis B vaccine with a Toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared to a licensed hepatitis B vaccine in healthy adults 40–70 years of age. Vaccine. 2013 Nov 4;31(46): 5300–5. PubMed PMID: 23727002. 10.1016/j.vaccine.2013.05.068
   PubMed Web of Science ®Google Scholar
• Indolfi G, Easterbrook P, Dusheiko G, et al. Hepatitis B virus infection in children and adolescents. Lancet Gastroenterol Hepatol. 2019 Jun;4(6):466–476. PubMed PMID: 30982722. doi: 10.1016/S2468-1253(19)30042-1
   PubMedGoogle Scholar
• Sandhu HS, Roesel S, Sharifuzzaman M, et al. Progress toward hepatitis B control — South-East Asia Region, 2016–2019. MMWR Morb Mortal Wkly Rep. 2020 Jul 31;69(30): 988–992. PubMed PMID: 32730237 PubMed Central PMCID: PMCPMC7392392 Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed. 10.15585/mmwr.mm6930a2
   PubMed Web of Science ®Google Scholar
• Miller KD, Gibbs RD, Mulligan MM, et al. Intradermal hepatitis B virus vaccine: immunogenicity and side-effects in adults. Lancet. 1983 Dec 24-31;2(8365–66): 1454–6. PubMed PMID: 6140546. 10.1016/s0140-6736(83)90800-0
   PubMed Web of Science ®Google Scholar
• Allen MI, Deslauriers M, Andrews CW, et al. Identification and characterization of mutations in hepatitis B virus resistant to lamivudine. Lamivudine clinical investigation group. Hepatology. 1998 Jun;27(6):1670–1677. PubMed PMID: 9620341. doi: 10.1002/hep.510270628
   PubMed Web of Science ®Google Scholar
• Yue T, Zhang Q, Cai T, et al. Trends in the disease burden of HBV and HCV infection in China from 1990-2019. Int J Infect Dis. 2022 Sep;122:476–485. PubMed PMID: 35724827. doi: 10.1016/j.ijid.2022.06.017
   PubMed Web of Science ®Google Scholar
• Nishida N, Sugiyama M, Sawai H, et al. Key HLA-DRB1-DQB1 haplotypes and role of the BTNL2 gene for response to a hepatitis B vaccine. Hepatology. 2018 Sep;68(3):848–858. PubMed PMID: 29534301; PubMed Central PMCID: PMCPMC6175380. doi: 10.1002/hep.29876
   PubMed Web of Science ®Google Scholar
• Huo TI, Wu JC, Lee PC, et al. Diabetes mellitus as a risk factor of liver cirrhosis in patients with chronic hepatitis B virus infection. J Clin Gastroenterol. 2000 Apr;30(3):250–254. PubMed PMID: 10777182. doi: 10.1097/00004836-200004000-00009
   PubMed Web of Science ®Google Scholar
• Frasca D, Diaz A, Romero M, et al. Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine. Vaccine. 2013 Aug 2;31(35):3603–3610. PubMed PMID: 23711934; PubMed Central PMCID: PMCPMC3760593. doi: 10.1016/j.vaccine.2013.05.003
   PubMed Web of Science ®Google Scholar
• Zhu H, Liu X, Ding Y, et al. Relationships between low serum vitamin D levels and HBV “a” determinant mutations in chronic hepatitis B patients. J Infect Dev Ctries. 2016 Sep 30;10(9):1025–1030. PubMed PMID: 27694737. doi: 10.3855/jidc.7459
   PubMed Web of Science ®Google Scholar
• Fusar-Poli P, Radua J. Ten simple rules for conducting umbrella reviews. Evid Based Ment Health. 2018 Aug;21(3):95–100. PubMed PMID: 30006442; PubMed Central PMCID: PMCPMC10270421. doi: 10.1136/ebmental-2018-300014
   PubMed Web of Science ®Google Scholar
• Ioannidis JP, Patsopoulos NA, Rothstein HR. Reasons or excuses for avoiding meta-analysis in forest plots. BMJ. 2008 Jun 21;336(7658):1413–5. PubMed PMID: 18566080; PubMed Central PMCID: PMCPMC2432114. 10.1136/bmj.a117
   PubMedGoogle Scholar